Baxter International Inc
BAX18.960USD
-0.110-0.58%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
9.74BCap. mercado
PérdidaP/E TTM
Más Datos de Baxter International Inc Compañía
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Información de Baxter International Inc
Símbolo de cotizaciónBAX
Nombre de la empresaBaxter International Inc
Fecha de salida a bolsaJun 20, 2097
Director ejecutivoHider (Andrew P)
Número de empleados38000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 20
DirecciónOne Baxter Parkway
CiudadDEERFIELD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60015
Teléfono12249482000
Sitio Webhttps://www.baxter.com/
Símbolo de cotizaciónBAX
Fecha de salida a bolsaJun 20, 2097
Director ejecutivoHider (Andrew P)
Ejecutivos de Baxter International Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+45.58%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+77.49%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+206.88%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
7.97K
+912.71%
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+45.58%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
Otro
391.00M
13.91%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.54B
54.66%
International
1.27B
45.34%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
Otro
391.00M
13.91%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
Otro
54.66%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
Otro
54.66%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor/Hedge Fund
47.20%
Investment Advisor
44.83%
Hedge Fund
2.90%
Research Firm
2.48%
Pension Fund
1.50%
Insurance Company
1.45%
Bank and Trust
1.22%
Sovereign Wealth Fund
1.14%
Individual Investor
0.46%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
1743
527.76M
108.76%
+72.60K
2025Q3
1826
527.84M
110.04%
+1.85M
2025Q2
1880
509.50M
105.73%
+4.72M
2025Q1
1916
504.93M
105.92%
-38.38M
2024Q4
1965
494.73M
105.04%
+14.02M
2024Q3
1980
482.92M
103.29%
+12.67M
2024Q2
2019
470.33M
102.19%
-1.85M
2024Q1
2069
469.00M
102.47%
-52.95M
2023Q4
2111
469.21M
101.33%
+9.34M
2023Q3
2090
463.57M
98.58%
+5.62M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
61.95M
12.06%
+1.13M
+1.85%
Jun 30, 2025
Dodge & Cox
52.12M
10.15%
+662.70K
+1.29%
Jun 30, 2025
Pzena Investment Management, LLC
55.46M
10.8%
+16.12M
+40.98%
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
29.85M
5.81%
-423.57K
-1.40%
Jun 30, 2025
BlackRock Financial Management, Inc.
18.73M
3.65%
+742.99K
+4.13%
Jun 30, 2025
State Street Investment Management (US)
21.94M
4.27%
+170.66K
+0.78%
Jun 30, 2025
T. Rowe Price Associates, Inc.
21.21M
4.13%
+1.64M
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
12.88M
2.51%
+326.65K
+2.60%
Jun 30, 2025
BlackRock Investment Management, LLC
7.81M
1.52%
+818.08K
+11.70%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Large Cap Value Active ETF
2.23%
First Trust Indxx Medical Devices ETF
1.69%
Invesco Raymond James SB-1 Equity ETF
1.5%
State Street SPDR S&P Health Care Equipment ETF
1.37%
Invesco S&P 500 Equal Weight Health Care ETF
1.26%
Franklin US Dividend Booster Index ETF
1.26%
iShares U.S. Medical Devices ETF
1.13%
Invesco Zacks Multi-Asset Income ETF
0.8%
Humankind US Stock ETF
0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.57%
Ver más
iShares Large Cap Value Active ETF
Proporción2.23%
First Trust Indxx Medical Devices ETF
Proporción1.69%
Invesco Raymond James SB-1 Equity ETF
Proporción1.5%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.37%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.26%
Franklin US Dividend Booster Index ETF
Proporción1.26%
iShares U.S. Medical Devices ETF
Proporción1.13%
Invesco Zacks Multi-Asset Income ETF
Proporción0.8%
Humankind US Stock ETF
Proporción0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proporción0.57%
Dividendos
Un total de
2.75B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 11, 2025
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option
Nov 28, 2025
Jan 02, 2026
Nov 28, 2025
Jul 14, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option
Aug 29, 2025
Oct 01, 2025
Aug 29, 2025
May 06, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option
May 30, 2025
Jul 01, 2025
May 30, 2025
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Baxter International Inc?
Los cinco principales accionistas de Baxter International Inc son:
The Vanguard Group, Inc. posee 61.95M acciones, lo que representa el 12.06% del total de acciones.
Dodge & Cox posee 52.12M acciones, lo que representa el 10.15% del total de acciones.
Pzena Investment Management, LLC posee 55.46M acciones, lo que representa el 10.80% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 29.85M acciones, lo que representa el 5.81% del total de acciones.
BlackRock Financial Management, Inc. posee 18.73M acciones, lo que representa el 3.65% del total de acciones.
The Vanguard Group, Inc. posee 61.95M acciones, lo que representa el 12.06% del total de acciones.
Dodge & Cox posee 52.12M acciones, lo que representa el 10.15% del total de acciones.
Pzena Investment Management, LLC posee 55.46M acciones, lo que representa el 10.80% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 29.85M acciones, lo que representa el 5.81% del total de acciones.
BlackRock Financial Management, Inc. posee 18.73M acciones, lo que representa el 3.65% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Baxter International Inc?
Los tres principales tipos de accionista de Baxter International Inc son:
The Vanguard Group, Inc.
Dodge & Cox
Pzena Investment Management, LLC
The Vanguard Group, Inc.
Dodge & Cox
Pzena Investment Management, LLC
¿Cuántas instituciones poseen acciones de Baxter International Inc (BAX)?
A fecha de 2025Q4, 1743 instituciones poseen acciones de Baxter International Inc, con un valor de mercado combinado de aproximadamente 527.76M, lo que representa el 108.76% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -1.28%.
¿Cuál es la mayor fuente de ganancias de Baxter International Inc?
El FY2025Q2, el segmento empresarial Infusion Therapies and Technologies generó la ganancia más alta para Baxter International Inc, ascendiendo a 1.02B y representando el 36.44% de la ganancia total.
